₹240.26
as on
as on September 8, 2025 at 4:01 pm IST
Day's Low
Day's High
1.31%
Downside
0.67%
Upside
52 Week's Low
52 Week's High
36.28%
Downside
36.54%
Upside
as on September 8, 2025 at 4:01 pm IST
Market Cap
₹1,601.22 Cr
Return on Equity (ROE)
18.58
PE Ratio (TTM)
0Return on capital employed (ROCE)
22.82
Beta (LTM)
1.65
P/B Ratio
3.95
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
102.63
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bearish
View Technical Analysis
Compare market cap, revenue, PE, and other key metrics of Jagsonpal Pharmaceuticals Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 1,601.22 | 313.3% | 0.00 | 55 | 268 | |
NA | 69.88 | 3.03% | 0.00 | 1 | 33 | |
NA | 44.49 | -17.01% | 0.00 | -22 | 104 | |
NA | 120.66 | 59.56% | 0.00 | 14 | 95 | |
NA | 162.34 | 98.3% | 0.00 | 6 | 113 |
Search interest for Jagsonpal Pharmaceuticals Ltd Stock has decreased by -76% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
Numbers in percentages
View detailed summary of the earnings and dividend history of Jagsonpal Pharmaceuticals Ltd.
Jagsonpal Pharmaceuticals Ltd’s net profit jumped 102.63% since last year same period to ₹10.80Cr in the Q1 2025-2026. On a quarterly growth basis, Jagsonpal Pharmaceuticals Ltd has generated 64.13% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Jagsonpal Pharmaceuticals Ltd has declared dividend of ₹5.00 per share on 20 May 2024 - translating a dividend yield of 4.16%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
FII Holding Up
Foreign Institutions have increased holdings from 2.10% to 2.18% in Jun 2025 quarter
Retail Holding Up
Retail Investor have increased holdings from 30.11% to 30.12% in Jun 2025 quarter
Price Dip
In the last 1 month, JAGSNPHARM stock has moved down by -5.9%
Promoter Holding Down
Promoters have decreased holdings from 67.78% to 67.65% in Jun 2025 quarter
Organisation | Jagsonpal Pharmaceuticals Ltd |
Headquarters | Gurgaon |
Industry | Pharmaceuticals |
CEO | Harsha Raghavan |
E-voting on shares | Click here to vote |
Jagsonpal Pharmaceuticals Ltd share price today stands at ₹240.26 as on at the close of the market. Jagsonpal Pharmaceuticals Ltd share today touched a day high of ₹241.88 and a low of ₹237.12.
Jagsonpal Pharmaceuticals Ltd touched a 52 week high of ₹328.04 and a 52 week low of ₹153.1. Jagsonpal Pharmaceuticals Ltd share price today i.e. is closed at ₹240.26, which is -26.76% down from its 52 week high and 56.93% up from its 52 week low.
Jagsonpal Pharmaceuticals Ltd market capitalisation is ₹1,601.22 Cr as on .
To buy Jagsonpal Pharmaceuticals Ltd shares, you need to follow these steps:
Jagsonpal Pharmaceuticals Ltd trading volume is 65.56K as on . This means that 65.56K shares of Jagsonpal Pharmaceuticals Ltd were bought and sold on the stock market during today's trading session.